Empowering the next generation of healthcare leaders
Novartis News Empowering the next generation of healthcare leaders
Novartis News Giving voice to people with a misunderstood disease
Novartis News Giving voice to people with a misunderstood disease
Novartis News Water project revives rural community in India
Novartis News Water project revives rural community in India
Novartis News A partnership against epilepsy
Novartis News A partnership against epilepsy
Novartis News Novartis Lutathera® significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced gastroenteropancreatic neuroendocrine tumors
Novartis Lutathera® significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced gastroenteropancreatic neuroendocrine tumors
arcticnovartis
- In the Phase III NETTER-2 trial, Lutathera plus octreotide LAR significantly extended median PFS to 22.8 months vs.
Novartis News Novartis shares strategy and growth update at J.P. Morgan Healthcare Conference 2024
Novartis shares strategy and growth update at J.P. Morgan Healthcare Conference 2024
imberje1
Follow us on Facebook
ADDRESS – ZIMBABWE
Suite 204, Block 1
Long Cheng Plaza
Mutley Bend, Belvedere
Harare, Zimbabwe
ADDRESS – ZAMBIA
Plot 43504
Apex Chalala
Off Kasama Road
Lusaka Zambia